The financing of research and innovation

The French government offers several tax incentives to encourage research and innovation in companies. One of these is the Research Tax Credit (Crédit d'Impôt Recherche or CIR), which allows eligible companies to deduct a portion of their research and development expenses from their taxable income. This can result in significant savings for companies that invest heavily in R&D. The innovation tax credit (CII) is an extension of the research tax credit (CIR) that applies to expenses related to prototypes and pilot installations of new products. Another tax incentive is the Innovation Tax Credit (JEI) In addition, young innovative companies may be eligible for the status of "Young Innovative Company" (Jeune Entreprise Innovante or JEI). This status provides eligible companies with several benefits, including reduced social security contributions for employees and a simplified R&D tax credit. This can help them to grow and develop new products, processes, and services. In the context of financing R&D and innovation, we propose securing all your CIR, CII and JEI technical files using all existing legal procedures. These are commonly known as tax ruling and validate the eligibility of ongoing or completed work with the competent authorities. Once project eligibility is validated, it is definitively acquired by the company.
The decision made by the competent authorities is binding on any subsequent tax audit, thereby securing your claims against facto vos créances sur l’état. Nous vous proposons de vous accompagnez pour sécuriser aussi bien votre crédit d’impôt recherche (CIR, innovation tax credit (CII), or status as a young innovative company (JEI). The choice is yours !

Rigaken_cercle

CIR

The Research Tax Credit rewards all companies taking the risk of carrying out research & development operations 

CII

The Innovation Tax Credit rewards all community-based SMEs that carry out innovation operations

JEI

The status of Young Innovative Company rewards new companies taking the risk of carrying out R&D operations